Ikuo Inoue et al. The New Molecular Entity Evolocumab,One Kind of PCSK9 Inhibitor, Reduce Plasma Small Size LDL-Cholesterol Levels by Using a New Standardized Method of Measuring LDL Size. Open Journal of Molecular and Integrative Physiology, 2017.7.1-23